Skip to main content

Advertisement

SpringerLink
Log in

T-Cell Lymphoma: Clinical Presentation and Therapeutic Outcome from a Tertiary Care Hospital in Eastern India

  • Medicine
  • Published:
SN Comprehensive Clinical Medicine Aims and scope Submit manuscript

Abstract

T-cell non-Hodgkin’s lymphoma (T-NHL) is rare and heterogeneous disease. There is a marked difference in biology, clinical presentation and therapeutic outcomes worldwide. This is a retrospective study from May 2014 to May 2018. Patients with established T-NHL after diagnosis were included, and their clinical presentation and therapeutic outcomes were analysed in detail. In the above-mentioned period, a total of 248 NHL patients were evaluated out of which 32(12.9%) had T-NHL. The median age of presentation was 37 years (range 7–69 years), with a male predominance 26 (81.2%). Most common presentation was painless lymphadenopathy 18 (56.2%). B symptoms were found in 8 (25%). In the Ann Arbor staging system, most T-NHL presented with either Stage III or IV with 12 (37.5%) patients respectively. Among the T-NHL subtypes, peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS), 20 (62.5%); anaplastic large-cell lymphoma (ALCL), 7 (21.9%); angioimmunoblastic T-cell lymphoma (AITL), 3 (9.4%); cutaneous T-cell lymphoma (CTCL), 2 (6.2%); and prolymphocytic leukaemia (PLL), 1 (3.1%) were diagnosed. Therapeutic options for T-NHL used were cyclophosphamide, doxorubicin, vincristine, prednisolone and etoposide (CHOEP) based. Response assessment after 6 cycles showed complete response (CR) and partial response (PR), 13 (40.6%) and 16 (50%), respectively. Three patients died during therapy. The progression-free survival (PFS) at 18 months was 57.34%. In our study, 12.9% patients had T- NHL among all patients of lymphoma. Lymphadenopathy and advanced stage disease were most common presentations. Chemotherapy outcomes showed CR in 40.6% of patients and PFS at 18 months was 57.34%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 2

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.

    PubMed  Google Scholar 

  2. Nair R, Arora N, Mallath M. Epidemiology of NHL in India. Oncology. 2016;91(suppl 1):18–25.

    Article  PubMed  Google Scholar 

  3. Park HS, McIntosh L, Braschi-Amirfarzan M, Shinagare AB, Krajewski KM. T-cell non-Hodgkin lymphomas: spectrum of disease and the role of imaging in the management of common subtypes. Korean J Radiol. 2017;18(1):71–83.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Osarogiagbon RU, Ramirez RA, Wang CG, Miller LE, McHugh L, Adair CA, et al. Size and histologic characteristics of lymph node material retrieved from tissue discarded after routine pathologic examination of lung cancer resection specimens. Ann Diagn Pathol. 2014;18(3):136–9.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Roy A, Kar R, Basu D, Badhe BA. Spectrum of histopathologic diagnosis of lymph node biopsies: a descriptive study from a tertiary care center in South India over 5½ years. Indian J Pathol Microbiol. 2013;56:103–8.

    Article  PubMed  Google Scholar 

  6. Elmore SA. Histopathology of the lymph nodes. Toxicol Pathol. 2006;34(5):425–54.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Garcia CF, Swerdlow SH. Best practices in contemporary diagnostic immunohistochemistry panel approach to hematolymphoid proliferations. Arch Pathol Lab Med. 2009;133:756–65.

    PubMed  Google Scholar 

  8. Naresh KN, Srinivas V, Soman CS. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2,773 lymphomas using REAL and WHO classification. Ann Oncol. 2000;II(supp 1):S63.

    Article  Google Scholar 

  9. Nair RA, Vasudevan JA, Jacob PM, Sukumaran R. Profiling of peripheral T-cell lymphomas in Kerala, South India: a 5-year study. Indian J Pathol Microbiol. 2017;60:206–8.

    Article  PubMed  Google Scholar 

  10. Arora N, Manipadam MT, Nair S. Frequency and distribution of lymphoma types in a tertiary care hospital in South India: analysis of 5,115 cases using the World Health Organization 2008 classification and comparison with world literature. Leuk Lymphoma. 2013;54:1004–11.

    Article  PubMed  Google Scholar 

  11. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Huang Y, Lin TY, Wu QL, Su ZL, Huang HQ, Xia ZJ, et al. Survival outcomes of T-cell non-Hodgkin's lymphoma: a report of 111 cases. Ai Zheng. 2005 Apr;24(4):470–4.

    PubMed  Google Scholar 

  13. Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST. T-cell non-Hodgkin lymphoma. Blood. 2006;107:1255–64.

    Article  CAS  PubMed  Google Scholar 

  14. Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Brière J, Haioun C, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Blood. 1998;92(1):76–82.

    CAS  PubMed  Google Scholar 

  15. Gutiérrez-García G, García-Herrera A, Cardesa T, Martínez A, Villamor N, Ghita G, et al. Comparison of four prognostic scores in peripheral T-cell lymphoma. Ann Oncol. 2011;22(2):397–404.

    Article  PubMed  Google Scholar 

  16. Poggio T, Duyster J, Illert AL. Current Immunotherapeutic Approaches in T cell Non-Hodgkin Lymphomas. Cancers. 2018;10(9):339.

    Article  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, N.R.S Medical College & Hospital, A.J.C Bose road, Kolkata, 700014, India

    Ankita Sen, Rajib De, Prakas Kumar Mandal, Shyamali Dutta, Shuvra Neel Baul, Tuphan Kanti Dolai & Prantar Chakrabarti

Authors
  1. Ankita Sen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rajib De
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prakas Kumar Mandal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shyamali Dutta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shuvra Neel Baul
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tuphan Kanti Dolai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Prantar Chakrabarti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shuvra Neel Baul.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Informed Consent

Patients were not required to give informed consent to the study because the analysis used clinical data from our departmental lymphoma registry that were obtained after each patient agreed to treatment by written consent.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Medicine.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sen, A., De, R., Mandal, P.K. et al. T-Cell Lymphoma: Clinical Presentation and Therapeutic Outcome from a Tertiary Care Hospital in Eastern India. SN Compr. Clin. Med. 2, 186–191 (2020). https://doi.org/10.1007/s42399-019-00215-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42399-019-00215-w

Keywords

Search

Navigation